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Abstract
Objectives—Despite well-known fitness advantages to males who produce and maintain high 
endogenous testosterone levels, such phenotypes may be costly if testosterone-mediated 
investment in reproductive effort trade-off against investment in somatic maintenance. Previous 
studies of androgen-mediated trade-offs in human immune function find mixed results, in part 
because most studies either focus on a few indicators of immunity, are confounded by phenotypic 
correlation, or are observational. Here the association between male endogenous testosterone and 
13 circulating cytokines are examined before and after ex vivo antigen stimulation with 
phytohaemagglutinin (PHA) and lipopolysaccharides (LPS) in a high pathogen population of 
Bolivian forager-horticulturalists.
Materials and Methods—A Milliplex 13-plex cytokine panel measured cytokine concentration 
in whole blood samples from 109 Tsimane men aged 40–89 (median=50 years) before and after 
antigen stimulation with PHA and LPS. Urinary testosterone was measured via enzyme 
immunoassay; demographic and anthropometric data were collected as part of the Tsimane Health 
and Life History Project.
Results—Higher endogenous testosterone was associated with down-regulated responses in all 
cytokines after PHA stimulation (but significantly in only 2/13 cytokines), controlling for age and 
body mass index. In contrast, testosterone was not significantly associated with down-regulation of 
cytokines after LPS stimulation. MANOVAs indicate that men with higher testosterone showed 
reduced cytokine responses to PHA compared to LPS (p=0.0098).
Discussion—Endogenous testosterone appears to be immunomodulatory rather than 
immunosuppressive. Potentially costlier forms of immune activation like those induced by PHA 
(largely T-cell biased immune activation) are down-regulated in men with higher testosterone, but 
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testosterone has less impact on potentially less costly immune activation following LPS 
stimulation (largely B-cell mediated immunity).
Keywords
Immunocompetence Handicap Hypothesis; phytohaemagglutinin (PHA); lipopolysaccharides 
(LPS); testosterone; Tsimane
Trade-offs between reproduction and longevity are among the most comprehensively 
researched areas of life history theory (Boddy et al. 2015; Kirkwood and Rose 1991; 
Muehlenbein and Bribiescas 2005). Testosterone and other steroid hormones play critical 
roles in the development and maintenance of many sexually dimorphic traits in males 
resulting from sexual selection (Andersson 1994), but at a cost; ceteris paribus, energetic 
investments in reproductive effort trade-off against investments in somatic maintenance 
(Folstad and Karter 1992; Muehlenbein and Bribiescas 2005). Since fitness gains of 
investment in reproduction earlier in life often outweigh the gains from somatic repair, 
reproduction is usually prioritized over longevity. Natural and controlled experiments 
provide evidence in favor of testosterone-mediated male survival, with castrated males living 
longer than intact males across many species including humans (Min et al. 2012).
One of the costlier forms of somatic investment in adulthood is immune function (Straub et 
al. 2010; Zuk and Stoehr 2002). Immune activation increases resting metabolism in humans 
and other species by 8–56%, and can incur caloric costs of up to 2000 kj/day −1 (Demas et 
al. 2011; Derting and Compton 2003; Muehlenbein et al. 2010; Straub et al. 2010). The 
Immunocompetence Handicap Hypothesis (ICHH) rose out of classical life-history theory 
and decades of research into costly signaling to become a dominant framework in the 
evolutionary ecology and behavioral endocrinology literature. It proposes that testosterone – 
as a critical mediator of male reproductive effort – suppresses immune function, and thus 
elaborate androgen-based traits represent an honest signal of male quality since only high 
quality males can afford to incur such costs (Folstad and Karter 1992; Furman et al. 2013; 
Zuk and Stoehr 2002). While the ICHH is a dominant theoretical model in the life history 
literature, evidence in favor of this hypothesis is limited, and other lines of research have 
suggested alternative models to explain associations between androgens and immune 
function (Foo et al. 2016; Nunn et al. 2009).
The immunosuppressive effects of exogenously administered testosterone are well 
documented from experimental studies of nonhuman animal models (Duffy et al. 2000; 
Peters 2000; Poiani et al. 2000; Yao et al. 2003). However, recent studies and meta-analyses 
find mixed evidence that endogenous testosterone is an active immunosuppressant in free-
living mammals (Foo et al. 2016; Nunn et al. 2009; Roberts et al. 2004). In fact, naturalistic 
studies often show positive associations between endogenous testosterone and induced 
antibody response, suggesting that males in good condition can afford to maintain both high 
testosterone levels and robust immune responses (i.e. positive phenotypic correlations) 
(Peters 2000; Rantala et al. 2012). These findings are bolstered by experimental work in a 
reptile model showing that immune function is enhanced when exogenous testosterone is 
paired with food supplementation, but without food supplementation exogenous testosterone 
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results in decreased innate immune function (Ruiz et al. 2010). Importantly, testosterone is 
down-regulated following infection and tissue injury, making it difficult to isolate the effects 
of testosterone on immune function in cross-sectional studies (Christeff et al. 1988; Spratt et 
al. 1993; Spratt et al. 2006). While meta-analyses suggest that testosterone is overall 
immunosuppressive (Foo et al. 2016), there is still ambiguity depending on which aspects of 
immune function are studied, and whether the impacts of testosterone on immune function 
are direct or indirect.
Another major issue is that most studies assessing trade-offs between immune function and 
testosterone rely on only a single biomarker of immune function, precluding the ability to 
examine a potential immuno-modulatory role of testosterone. Immune function involves 
multiple coordinated responses, each with their own costs, benefits and interactions with 
other immune and endocrine responses. Numerous cytokines, for example, play critical roles 
in immune cell signaling and lymphocyte differentiation and have varying impacts on 
physiology and varying energetic costs (Table 1). As an alternative to the ICHH, it has been 
proposed that testosterone is immuno-modulatory rather than immunosuppressive, that is, 
testosterone regulates trade-offs between different types of immune response (Muehlenbein 
and Bribiescas 2005; Simmons and Roney 2009). If only the energetically costlier forms of 
immunity are downregulated in higher testosterone males, then energetic availability may 
underlie some of the associations reported in the literature. Indeed, evidence suggests that 
energetic costs (e.g. from illness, fasting) can impact both testosterone levels and immune 
function (Scrimshaw and SanGiovanni 1997; Spratt et al. 1993; Trumble et al. 2010). The 
ability to mount a rapid response to local infection or tissue injury is of particular utility, as 
high testosterone males more frequently engage in aggressive physical competition with 
other males (Archer 2006). In mandrills, male-male competition in the form of physical 
aggression is a common route for spreading simian immunodeficiency virus (SIV) 
(Nerrienet et al. 1998), while physically aggressive interactions between wild rodent males 
increase transmission rates of hantavirus (Glass et al. 1988). Innate immune responses, 
which include pro- and anti-inflammatory cytokines, not only are crucial rapid responses to 
injury, but also play a role in subsequent wound healing (Werner and Grose 2003). In free-
ranging baboons, where success in male-male physical conflict determines males’ 
reproductive access to females, high status males – who have higher testosterone than 
subordinate males (Gesquiere et al. 2011) – heal faster than subordinates (Archie et al. 
2012), perhaps because of positive phenotypic correlation. Thus, while there may be trade-
offs between testosterone and some more energetically costly aspects of immune function 
(Best and Hoyle 2013), one would not expect that testosterone would down-regulate all 
aspects of immune function equally.
Studying the role of testosterone in modulating immune function under naturalistic 
conditions is notoriously difficult in humans, where ethical concerns limit the use of various 
experimental protocols commonly used in nonhuman animal models. Observational studies 
demonstrate that testosterone decreases immediately following illness or injury (Christeff et 
al. 1988; Muehlenbein et al. 2010; Spratt et al. 1993; Spratt et al. 2008), which is consistent 
with a life history framework which posits that energetic stress shunts caloric resources from 
investment in reproductive effort (often proxied by a high testosterone phenotype) toward 
immune function. While it is clear that any energetic stress, whether due to immune 
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activation from infection (Muehlenbein et al. 2010) or caloric restriction (Trumble et al. 
2010), results in decreased testosterone production, it is less clear that endogenous 
testosterone actively down-regulates human immune function. Indeed, a longitudinal study 
of Filipino males found a positive association between testosterone and immunoglobulin A 
(sIgA), a marker of mucosal immunity (Gettler et al. 2014).
Study goals and hypotheses
This study contributes to the literature with 1) data from a free-living energy limited 
population living a relatively traditional lifestyle, 2) use of multiple measures of immune 
activation, and 3) measurement of biomarkers at baseline and following an ex vivo 
challenge. The analyses herein focus on 109 older adult men (aged 40–89 years, median 
age=50 years) in a population of forager horticulturalists facing high pathogen burden 
(Gurven et al. 2008). In this immunologically stressed population, we expect energetic trade-
offs between testosterone and immune function to be stronger than that observed among 
energetically replete industrialized populations with lower infectious burden (Blackwell et 
al. 2015; Gurven et al. 2008). Additionally, industrialized populations have significantly 
higher levels of testosterone at younger ages compared to subsistence populations, and 
steeper age-related declines (Ellison et al. 2002; Trumble et al. 2012).
Most prior observational studies in humans have only measured circulating concentrations of 
immune markers under baseline conditions, as opposed to the immune response to 
challenge. Recent studies indicate that immune response to challenge is far costlier than 
baseline immune function, both in nonhuman animal models (Demas et al. 2011; Derting 
and Compton 2003) and humans (Muehlenbein et al. 2010). Given behavioral effects of 
androgens (e.g. (Archer 2006)), individuals with higher testosterone may also engage in 
behavior that increases the likelihood of wounding or encountering pathogens (e.g. increased 
male-male competition) (Klein 2000).
In this study, levels of urinary testosterone are examined in relation to 13 circulating 
cytokines following ex vivo whole blood antigen stimulation with a T-cell mitogen, 
phytohaemagglutinin (PHA) and a B-cell mitogen, lipopolysaccharides (LPS). PHA is a 
commonly used mitogen that activates the division and replication of T-cells, while LPS is a 
cell wall component of gram negative bacteria that binds to toll-like receptor 4 (TLR4) and 
initiates B-cell division and differentiation into plasma cells as well as activation of 
macrophages, monocytes, and dendritic cells (Ceuppens et al. 1988; Heumann and Roger 
2002; Wheelock 1965). This study can therefore examine androgen mediated immuno-
modulation in response to several common immune challenges facing humans. This 
experimental approach has major advantages; first, we are able to stimulate an immune 
response ex vivo which permits intra- and inter-individual comparisons in cytokine response 
to the same challenge controlling for baseline cytokine levels and other potential 
confounders. Additionally, while under normal physiological conditions circulating 
testosterone rapidly decreases following infection or tissue injury (Christeff et al. 1988; 
Simmons and Roney 2009; Spratt et al. 1993; Spratt et al. 2008), using an ex vivo design we 
can examine the relationship between baseline testosterone and cytokine response to 
stimulation without any potential for steroidal down regulation post-infection.
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Given the advantages of this experimental design over previous observational studies, we 
hypothesize that we will have a level of contrast necessary to differentiate between broad 
immunosuppression versus immunomodulation of specific aspects of immune function. We 
hypothesize that higher endogenous testosterone will be associated with more down-
regulation of energetically costly aspects of immune function, such as T-cell mediated 
immune responses, but not broad, generalized immunosuppression.
MATERIALS AND METHODS
Ethics statement
For all protocols institutional (UCSB and UNM) IRB approval was granted, as was informed 
consent at three levels: 1) Tsimane government that oversees projects, 2) village leadership, 
and 3) study participants.
Bio-specimen collection and preparation
Tsimane men (n=122) came to the Tsimane Health and Life History Project’s (THLHP) 
clinic in San Borja, Beni, Bolivia to participate in THLHP protocols (e.g. economic and 
demographic interviews, biospecimen collection), and to receive a routine medical exam as 
part of the project’s behavioral-biomedical surveillance. All Tsimane aged 40+ were invited 
to participate in this and other studies regardless of their health status, and approximately 
85% of adults participated. Prior to the medical exam and interviews, men provided a first 
morning void urine specimen. Fasting blood was drawn, both with and without heparin as an 
anti-coagulant. One vacutainer of blood without anti-coagulant was allowed to clot, and then 
serum was separated via centrifugation (1500g × 10 minutes) and frozen in liquid nitrogen. 
Multiple 100 μL aliquots of heparinized whole blood were immediately added to separate 
round bottom microtiter wells in a sterile 96-well plate. The first aliquot received 100 μL of 
20 μg/mL phytohaemagglutinin (PHA, Sigma cat. 61764) diluted in RPMI-1640, for a final 
concentration of 10 μg/mL PHA. The second aliquot received 100 μL of 20 μg/mL 
Lipopolysaccharides (LPS. Sigma cat. L2630) diluted in RPMI-1640, for a final 
concentration of 10 μg/mL LPS. A third aliquot was mixed with 100 μL RPMI-1640 without 
mitogens. In all three cases, RPMI was supplemented with 100 IU/ml penicillin and 100 
μg/ml streptomycin (Sigma cat. P0781) to prevent contamination. In the absence of a CO2 
incubator in the San Borja clinic, the microtiter plate was sealed in a glass Tupperware with 
a lit candle, which burned the O2 in the container, thus enriching the CO2 concentration 
(May et al. 2009). The sealed plates were incubated at 37°C for 72 hours. Following this, the 
supernatant was removed and frozen in liquid nitrogen for transport to UNM. Specimens 
were transported on dry ice and stored at −80°C for up to two years before assay.
Biomarkers of immune activation
Immediately following the blood draw, leukocyte counts were measured with a QBC 
Autoread Plus (QBC Diagnostics). For both baseline (unstimulated) serum specimens and 
post-stimulation whole blood specimens, 13 cytokines (TNF-α, INF-γ, IL-1β, Il-2, IL-4, 
IL-5, IL-6, IL-7, IL-8, IL-10, IL-12p70, IL-13, and GM-CSF) were measured with a 
Milliplex MAP High-Sensitivity Human Cytokine Panel (HSCYTO-60, Millipore Corp., 
Billerica, MA) on the Luminex MagPix, at the Hominoid Reproductive Ecology Laboratory 
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at the University of New Mexico. Following manufacturer recommendation, calibrators were 
prepared with a serum matrix for baseline specimens, and with RPMI for antigen-stimulated 
samples, and specimens below the limits of detection were assigned the lower limit of 
detection. Quality control specimens were within expected ranges provided by the 
manufacturer.
C-Reactive Protein (CRP) was measured at the UCSB Human Biodemography lab via 
enzyme immunoassay (Brindle et al. 2010). Within and between plate coefficients of 
variation (CVs) were 7.3% and 10.2% for the high and 5.3% and 9.2% for the low controls.
2.4 Urinary testosterone
Though both urine and serum samples were obtained, we elected to assess testosterone in 
urine because urine samples reflect testosterone production over a longer period and are less 
susceptible to transient fluctuations. Since a large proportion of testosterone in urine is 
present in its conjugated form of testosterone glucuronide, we first deconjugated samples 
with beta-glucuronidase (Helix pomatia, Calbiochem, <2% aryl sulfatase activity) and ether 
extraction. Testosterone was measured with an in-house enzyme linked immunosorbent 
assay (ELISA) using a polyclonal antibody (R156/7, provided by C. Munro at the University 
of California-Davis) which cross reacts 100% with testosterone, 57.4% with 5α-
dihydrotestosterone, 0.27% with androstenedione, and <0.05% with other androgens (Muir 
et al. 2001). Within and between plate CVs were 4.7% and 12.2% for the high and 4.7% and 
14.9% for the low controls. Urinary testosterone was corrected for specific gravity (Miller et 
al. 2004).
Statistical Methods
From the initial sample of 122, males with acute infections (CRP >10 mg/L, n=12), were 
removed prior to analyses. Additionally, one individual was missing testosterone data. Three 
individuals were missing PHA stimulation data and six individuals LPS stimulation data, 
due to contamination of samples during field procedures. Final sample sizes were 103 for 
LPS analyses, 106 for PHA analyses, and 109 for combined analyses. Cytokines (baseline 
and ex vivo stimulated) and testosterone values were logged to normalize distributions 
unless otherwise noted, and converted to Z-scores. Cytokines were normalized across all 
stimulation conditions to place all cytokines on a similar scale, and allow for simultaneous 
testing of effects across multiple cytokines. A second set of z-scores were also normalized 
only within a particular stimulation type, to allow comparison of relative cytokine changes 
under particular mitogen stimulation conditions. Models reported in the paper indicate 
which z-scores were utilized for a particular analysis. Mitogen stimulations were run in 
batches on a given day, and each batch was grouped together and treated as a random effect 
to control for potential non-independence due to field conditions (e.g. temperature 
fluctuations) or plate characteristics. Linear mixed model analyses examined associations 
between mitogen type, cytokine type, testosterone, and cytokine response, controlling for 
age, BMI, CRP, and baseline cytokines as fixed effects, and subject and batch as random 
effects, using lme in the nlme package in R. Models were fit with restricted maximum 
likelihood (REML). We then used anova on our lme models to assess significance of 
multilevel factors (Pinheiro and Bates 2006). Additional exploratory linear mixed effects 
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regression models examined associations between testosterone and each individual cytokine 
response to both PHA and LPS stimulation (z-scored), controlling for fixed effects of age, 
BMI, CRP and baseline cytokine, and a random effect of batch. We utilize an α= 0.05 as the 
cutoff for statistical significance. P-values are not Bonferroni corrected as the tests are not 
independent (cytokines interact and covary), violating the independence requirement of a 
Bonferroni correction. Interaction terms (e.g. testosterone by BMI) were assessed, but did 
not achieve statistical significance and are thus omitted. Statistical analyses were conducted 
in R 3.2.2 (https://cran.r-project.org/).
RESULTS
3.1 Testosterone and baseline characteristics
Urinary testosterone was not associated with baseline immune parameters, including overall 
baseline serum cytokines (β = 0.026, t = 0.44, p = 0.658) or any individual cytokine level (all 
p’s > 0.19). Baseline total leukocyte (β = −0.011, t = −0.05, p = 0.962) counts were not 
associated with testosterone level.
Cytokine response to T- and B-cell mitogens
Cytokine responses to each of the mitogens are categorized in Figure 1A and Tables 2–6 and 
S1–4. Comparing across mitogens, cytokine responses differ significantly (p < 0.001) 
between PHA and LPS stimulation (Table 3; Figure 1A), with PHA characterized by high 
IL-2, IL-4, IL-5, and IL-13, and LPS characterized by high IL-12p70, IL-10, TNFα, and 
IL-1 β. The remaining cytokines (IL-7, INF-γ, GM-CSF, IL-8, IL-6) showed intermediate 
responses to both mitogens (Figure 1A). There was no clear trend for the RPMI only 
stimulation condition (Figure 1A).
Impact of endogenous testosterone on the cytokine response to T- and B-cell mitogens
Testosterone was a significant predictor of overall cytokine response to PHA (β = −0.131, t 
= −2.01, p = 0.049), although the effect is not specific to particular cytokines (no significant 
interaction with cytokine type; Table 2). Testosterone was not a significant predictor of 
overall cytokine response to LPS (β = −0.003, t = −0.06, p = 0.479). These results were 
unchanged when controlling for leukocyte count (Table S1).
Testosterone levels interacted with mitogen stimulation type; there was a negative 
testosterone by PHA interaction (Table 3). Higher testosterone is generally associated with 
lower cytokine production after PHA stimulation and in RPMI medium alone. Normalizing 
for stimulation type illustrates this further (Figure 1B), by illuminating only the testosterone-
associated variance in cytokine levels.
Testosterone and individual cytokine response to ex vivo antigen stimulation
Our models suggested that effects of testosterone are on overall cytokine response to PHA, 
and not on particular cytokines. To verify this we performed exploratory analyses examining 
each cytokine individually (Tables 4–6). Controlling for baseline cytokine level, age, CRP, 
and BMI, testosterone was negatively associated with all 13 PHA-stimulated cytokines, 
significantly so with only GM-CSF and IL-8, but with suggestive trends for IL-2, IL-7, and 
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IL-13 (Table 4). Ten of 13 cytokines had standardized parameter estimates < −0.1, with only 
IL-1β, IL-6, and IL-4 showing little evidence of association. Testosterone was not 
significantly associated with any cytokine following LPS stimulation (Table 5), and with 
LPS stimulation, only two cytokines had standardized parameters < −0.1 or > 0.1: IL-1β was 
positively associated with testosterone (β = 0.148, p = 0.132) and IL-2 was negatively 
associated (β = −0.125, p = 0.165). These results were unchanged when controlling for 
leukocyte count (Tables S2–S4).
DISCUSSION
This study tested trade-offs among older Tsimane men between androgens and immune 
activation biomarkers by examining associations between endogenous testosterone and 
mitogen-stimulated cytokine levels. Our results indicate that endogenous testosterone is 
associated with immuno-modulation, or at least selectively suppressive as opposed to 
broadly immunosuppressive. Testosterone is associated with reduced cytokine responses 
following stimulation with a T-cell mitogen, PHA, while testosterone has no significant 
association with response to stimulation with a B-cell and monocyte mitogen, LPS. These 
results fit within a larger life-history and ecological immunology literature suggesting that 
men with higher levels of testosterone downregulate some, but not all aspects of immune 
activation. In this case we find an association suggesting that cytokine responses to T-cell 
mitogens are downregulated in higher testosterone males. Unlike B-cells, which can 
continue to produce relatively long lasting antibodies, cytotoxic T-cells must be continually 
produced and clonally expanded in large numbers. From an energetic perspective, T-cell 
mediated immune activation may be more costly than B-cell mediated immune activation 
due to this need to produce many cells (Lochmiller and Deerenberg 2000). Thus testosterone 
appears to selectively downregulate the most energetically expensive forms of immune 
activation, which is expected if testosterone serves an adaptive immuno-modulatory 
function, especially in energy-limited subsistence populations.
Stimulation with PHA results in an immune response similar to that expected with exposure 
to viral infection (Ceuppens et al. 1988; Wheelock 1965), and tends to cause greater changes 
in IL-2, IL-4, IL-5, and IL-13 (Table 1, Figure 1A). In animal models, treatment with 
testosterone results in reduced response to viral infections, as measured by higher viral titers 
(Lindström et al. 2001). Research on humans indicates that men are more susceptible to viral 
infections than women, and also that testosterone is down-regulated in men infected with 
diverse viruses ranging from influenza vaccinations to HIV (Grinspoon et al. 1996; Klein 
2000; Simmons and Roney 2009). If men with higher testosterone have a decreased cytokine 
response to viral infection, then reducing levels of testosterone following infection would be 
an optimal response. Indeed, studies find decreases in testosterone following illness and 
tissue injury (e.g (Christeff et al. 1988; Muehlenbein and Bribiescas 2005; Spratt et al. 1993; 
Spratt et al. 2008)). Testosterone can be lowered by decreasing hypothalamic-pituitary-
gonadal production, or by increasing aromatization of testosterone to estrogen (Spratt et al. 
2006). Changes in testosterone and other biomarkers during and following illness may 
underlie some sickness behaviors like reduced physical activity and other depressive 
symptoms (Shattuck and Muehlenbein 2015; Stieglitz et al. 2015).
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Contrary to the results from PHA stimulation, cytokines produced by stimulation with LPS 
were not associated with testosterone. LPS stimulates B cells as well as macrophages, 
monocytes, and dendritic cells. Macrophages in particular may be important in response to 
injury, and so the maintenance of their activity with elevated testosterone might be 
important. However, B-cells are much more abundant in Tsimane blood compared to 
industrialized populations, while monocytes are very rare (Blackwell et al. 2016), so much 
of the LPS response is likely a B-cell response. Unlike T-cells that are lysed when 
destroying infections, B-cells that remain inactive are relatively low cost reservoirs that can 
be activated to produce antibodies as needed (McDade et al. 2016). While the developmental 
costs of producing B-cells and immunoglobulins can be high, the maintenance and activation 
costs are relatively low, as are the collateral costs in terms of tissue damage when activated 
(McDade et al. 2016). For a 10 kg human infant, the total cost of producing immunoglobulin 
G (IgG) is approximately 0.043% of their daily protein budget, while the costs of B-cell 
proliferation during infection is estimated to be 0.00048% of this budget (McDade et al. 
2016; Waterlow 1984). Immunoglobulins have a half-life of approximately 25 days, and thus 
once produced, antibodies have protective effects that require little additional energetic 
maintenance or input (Mankarious et al. 1988). On a-cell-by-cell cost, B-cells and T-cells 
likely have similar costs. However, T-cells are 2–3 times more common in the blood, and for 
this reason alone may require more overall resources (Bisset et al. 2004; Blackwell et al. 
2016). Thus from an energetic perspective, T-cell mediated immune activation may be 
energetically costlier than B-cell mediated immune activation. Testosterone perhaps may be 
down-regulating the most energetically expensive forms of immune activation, which is 
expected if testosterone serves an adaptive immuno-modulatory function.
There are well-characterized impacts of testosterone on both T-cells and B-cells. Evidence 
suggests that testosterone can bind to, and actively inhibit T-cell differentiation and 
proliferation (Benten et al. 1999; Kissick et al. 2014; McMurray et al. 2001). B-cells do not 
express surface androgen receptors (Benten et al. 2002), and testosterone does not appear to 
be associated with differences in B-cell proliferation (McMurray et al. 2001), though 
treatment with exogenous testosterone does decrease antibody production in animal models 
(Kanda et al. 1996). Previous studies report positive associations between androgens and 
anti-inflammatory cytokines (Liva and Voskuhl 2001; Malkin et al. 2004). While the results 
in the present study do not replicate these findings, there are several confounding factors that 
make direct comparisons difficult. First, those studies used exogenous testosterone 
administration, which while an excellent way to isolate the impact of testosterone on 
cytokines may not be ecologically valid, as many aspects of physiology other than just 
androgens are modified when androgens naturally increase. Other studies using exercise to 
naturalistically manipulate testosterone do not find the same associations between 
testosterone and IL-10 (Benini et al. 2015). Secondly, Tsimane have significantly lower 
levels of age-matched testosterone than males living in industrialized populations (Trumble 
et al. 2012), and thus the low levels seen in this population, and perhaps throughout much of 
human evolution, may potentially have had less of an impact on anti-inflammatory cytokines 
than the relatively high levels seen in men in industrialized populations and men taking 
exogenous testosterone.
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Our study finds associations between endogenous testosterone and cytokine production. 
However, there may be multiple mechanisms through which this effect could occur. 
Endogenous testosterone is present in the blood samples used for stimulation, and may act 
directly on leukocytes at the time of stimulation. Alternatively, long term differences in 
testosterone may have effects on leukocyte phenotypes that affect responsiveness to 
stimulation, irrespective of levels in the blood at the particular time of stimulation. Androgen 
receptors are present on T-cells (Benten et al. 1999), but their numbers might be dynamically 
regulated in response to baseline androgen levels and other feedback mechanisms. 
Additionally, developmental changes at early ages may have led to differences between 
individuals in both testosterone and immune function, leading to associations that are not 
necessarily causal, but rather correlates of other phenotypic variables.
These hypotheses are not mutually exclusive, and we think it likely that all three of these 
pathways might be important. Our results suggest that testosterone is not associated with 
baseline cytokines or leukocyte counts, yet there are other ways immune function might vary 
as a function of disease or developmental history. Future studies will be needed to separate 
these causal mechanisms more carefully.
There are several reasons why our results may differ from other studies of the ICHH. The 
immune system is multifaceted and these studies differ in the type of immune activation 
being studied. While a recent meta-analysis found support for testosterone down-regulating 
many aspects of immune function, it notes significantly more variation and less consistency 
across 19 studies examining impacts of testosterone on cytokines compared to other markers 
of immune function (cell-mediated, humoral, parasitic white blood cell based studies) (Foo 
et al. 2016). Cytokines are just one aspect of immunity, and while the results reported here 
are consistent with the notion that testosterone is immuno-modulatory in contrast to the 
ICHH as originally formulated, further research is needed. A more direct test of immuno-
modulation would involve manipulation of testosterone levels, though such an experimental 
design would have reduced ecological validity. Additionally, the participants in this study 
were on average older than some previous studies (see limitation section below).
Trade-offs between reproduction and survival are one of the most studied life-history trade-
offs. Quasi-experimental studies like the one conducted here suggest that ceteris paribus, 
higher testosterone males show down-regulated immune response to some, but not all, 
components of immune function, implicating testosterone as a potential immuno-
suppressant to some of the energetically costlier aspects of human immune function. That 
said, there is no single global measure of immune function; instead millions of years of 
evolution have shaped a system to fight multiple pathogens in myriad ways through 
numerous physiological pathways. So while higher endogenous levels of testosterone may 
down-regulate some aspects of immune function (e.g. cytokine response to T-cell mitogens), 
that does not mean that testosterone is generally immuno-suppressive; indeed cytokine 
responses to B-cell mitogens were largely unaffected by testosterone. Additionally, relatively 
long-lived humans invest more in some aspects of immune function and survival compared 
to species with faster life histories (i.e murine models) which prioritize early reproduction 
(Lee 2006). Thus while we find little evidence of the ICHH in humans, these results may not 
be applicable to other species with faster life history strategies.
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Much of the previous research into immune-testosterone links have been conducted in 
seasonally breeding birds or mice, which may not offer a good model of human immune 
function (Greenman et al. 2005; Warren et al. 2014). In seasonal breeders, more than just 
circulating testosterone changes during the mating season; major changes are observed in 
energy expenditure, sleep, body composition, social behavior, and food consumption, all of 
which can alter immune function (Greenman et al. 2005). Tsimane are exposed to high 
pathogen loads (Blackwell et al. 2015; Gurven et al. 2008) which also vary seasonally and 
may predispose their immune system to be less reactive to minor insults like antigen 
stimulation (McDade et al. 2010), or alternatively primed to respond to any type of insult. 
These alternative hypotheses require further testing. Because Tsimane men have lower levels 
of testosterone compared to men in industrialized populations (Ellison et al. 2002; Trumble 
et al. 2012), Tsimane men may not experience the kind of generalized immunosuppression 
observed when superphysiological levels of testosterone are exogenously applied to 
nonhuman animal models (Duffy et al. 2000; Peters 2000; Poiani et al. 2000; Yao et al. 
2003). Previous research among the Tsimane also found no evidence that disease symptoms 
(e.g. diarrhea, respiratory illness, injuries) from clinical exams were associated with 
testosterone in a small sample of men (Trumble et al. 2013).
Strengths and Limitations
A strength of our study design is that we tested the impact of two different mitogens across 
13 cytokines; had we just focused on only PHA or LPS we would have had different results 
and interpretations. While ex vivo whole blood antigen stimulation only provides a small 
window into the role of testosterone in modulating immune function, it is also a powerful 
tool that allows us to examine immune responses that would otherwise be unethical or 
impossible to study in non-laboratory settings. This experimental protocol also avoids 
confounding by ensuring that all specimens receive the same pathogenic exposure, and that 
androgens do not down-regulate following illness, both of which are critical for 
understanding the role of these steroids in affecting immune function. While antigen 
stimulation is beneficial for isolating the role of steroids on specific aspects of immune 
activation, it is not guaranteed that the response from ex vivo stimulation will match the 
myriad potential additional responses in a living human. Nonetheless this demonstrates the 
importance of field-friendly experimental manipulations; had this been a purely 
observational study of baseline cytokines and testosterone we would have observed no 
relationship between testosterone and circulating cytokines (see results above). This study is 
also limited by focusing solely on males, and on older males over age 40; the immuno-
modulatory effects of testosterone could potentially be stronger in younger males who are 
investing more energy in reproductive effort. Additionally, given changes in immune 
function with age among the Tsimane (Blackwell et al. 2016), it is possible that baseline 
cytokines, or cytokine responsiveness may differ at younger ages. This does not diminish the 
results of this study; with modal ages of death in the 70s, a 45 year old Tsimane male can 
expect to live an additional 25.6 years of life (Gurven et al. 2007), and thus trade-offs 
between androgens and immune function still have important consequences even at later 
ages. With the rise of testosterone replacement therapies in industrialized populations (Gan 
et al. 2013), these results could also be of interest to the wider biomedical community as 
more older men are exposed to higher doses of testosterone. Some might argue that results 
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from populations like the Tsimane are not generalizable to industrialized populations, but we 
argue that they represent a crucial step toward understanding human immune and endocrine 
physiology, which evolved under very different conditions than those observed in modern 
settings with less pathogen exposure.
CONCLUSIONS
Testosterone is more strongly associated with cytokine down-regulation in response to PHA 
stimulation, which induces a largely T-cell mediated response; stimulation with LPS (largely 
biased toward B-cell immunity) did not result in generalized immunosuppression. It is clear 
from these results that steroid hormones are associated with differential cytokine responses 
to different mitogen types, a result that would not have been found focusing solely on one 
mitogen or one biomarker of immune function, or if relying only upon (unstimulated) 
baseline circulatory cytokines. Future studies will focus on the differential impacts of 
testosterone and other steroid hormones on cytokine response to additional mitogen types 
and using a wider age range and across sexes, to better understand the role of such hormones 
in modulating immune function. Parasites, bacterial infections, and viruses were all major 
selective pressures throughout human evolution, and understanding the impact of steroids on 
immune responses to each of these infections can provide greater understanding of trade-offs 
between reproductively beneficial androgens and longevity.
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Figure 1. 
Mean normalized cytokine levels under each stimulation condition relative to normalized 
testosterone. Conditions include medium only (RPMI) or stimulation with a B-cell and 
monocyte (LPS) or a T-cell mitogen (PHA). A) Mean cytokine levels for each stimulation 
condition. Each cytokine is normalized across all conditions in order to show variation 
across stimulation types, while eliminating the absolute differences in level between 
different cytokines. B) Mean cytokine levels within each stimulation condition, relative to 
testosterone level. Cytokines are normalized within each mitogen condition to show only 
variation associated with testosterone. Higher testosterone is generally associated with lower 
cytokine production after PHA stimulation and in RPMI medium alone. All z-scores were 
calculated by first logging cytokine or testosterone values, and then subtracting the mean 
and dividing by the standard deviation. Both A and B show the predicted values from the 
mixed models shown in Table 3, controlling for BMI, baseline serum cytokine levels, 
baseline CRP, and analysis batch.
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Table 1
Cytokine response to antigen type, see figure 1.
Response to Mitogen Cytokine Produced By Role
IL-2 T cells Triggers T-cells to become effector cells, Expansion of T-
cell clones
Stronger PHA Cytokine 
Response
IL-4 Basophils may be initial effector, Th2 
cells (auto)
Differentiates B cells to plasma cells, B-cell IgE class 
switching
IL-13 T cells Induce IgE secretion, physiological changes in parasitized 
organs
IL-5 T cells, Eosinophils B-cell growth, Ig secretion, Eosinophil activation
IL-7 Dendritic cells, NOT lymphocytes Proliferation of all lymphocytes
INF-γ NK and NKT cells, Th1 CD4 and 
CD8 effector cells
Activates macrophages, inhibits viral replication
Intermediate Response to 
both PHA and LPS GM-CSF
Macropahges, T cells, Mast Cells, NK 
Cells Granulocyte and monocyte production
IL-8 Macrophages Neutrophil chemotaxis
IL-6 T cells, macrophages energy mobilization, temperature increase, B cell growth, 
T-reg antagonism
IL-12p70 Dendritic cells, macrophages, 
immature B cells
T cell growth, UP IFN-g, TNF-a from T and NK, down 
IL-4. Increases toxicity of NK and CD8. IL-2 ups IL-12 
receptors, enhancing the effect
IL-10 Monocytes, Th2 (less), Treg, cytotoxic 
T-cells to inhibit NK in response to 
virus
Negative feedback on self, down regulates MHC II, 
Enhances B cell, down regulates IFN-γ, IL-2,IL-3, TNF-α, 
GM-CSF
Stronger LPS Cytokine 
Response
TNF-α Macrophages, CD4, NK Fever, inflammation, apoptosis
IL-1β Activated macrophages Lymphocyte activator
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